This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event September 28 - October 6, 2021
In-Person September 28-29 | Virtual October 5-6Philadelphia, PA

Catherine Gray, PharmD
Acting Director, Office of Prescription Drug Promotion (OPDP) at U.S. Food and Drug Administration

Profile

Catherine Gray leads the Office of Prescription Drug Promotion (OPDP) at the FDA. Her diverse team of professionals focuses on the challenging and evolving policy and operational issues pertaining to the promotion of prescription drugs. She oversees policy development, social science research, regulatory counseling, compliance activities, stakeholder engagement, and operational support to the office as it realizes its mission to protect the public health. Her over twenty years of experience include roles in clinical pharmacy and the pharmaceutical industry. Dr. Gray received her B.S. from the University of Notre Dame and her Doctor of Pharmacy from Campbell University. She completed Fellowships with Rutgers University and the Partnership for Public Service.